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Correction
A confocal image in Figure 3B of Hauser et al. 2010 [1],
showing TGN staining of Vphu-HcRed expressing cells
(middle row,) was incorrect. This image has now been
replaced with the correct image.
Additional material
Additional file 1: Updated versions of Figure 3 of Hauser et al. 2010
[1]. Redistribution of tetherin to an intracellular compartment by HIV anti-
tetherin factors. (A) The percentage of HeLa cells displaying tetherin
concentrated in a perinuclear compartment (PNC) was calculated for 100
cells, from either control (Ctrl.) cells or cells transfected with 2 μg of Vpu
or ROD10 Env expression plasmids. Mean +/- SEM is shown for n = 2
independent experiments. (B) HeLa cells transfected with either Vpu
(Vphu-HcRed) or ROD10 Env, showed increased concentration of tetherin
in a perinuclear compartment (arrowed), that co-stained with the TGN
marker, TGN46. The triple color merged image is shown. Scale bars
represent 10 μM.
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